The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we're gonna start cutting down the lipitor until we get that des master all to bump and so we're still in the process of doing that actually so that to me is like kind of a an example of what I would think of as hopefully where precision medicine would be going which is you're now well outside of a clinical trial
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and we just in that situation based on all the reasons you've laid out play to the precautionary principle and frankly you know our application of that is there's probably only two patients in my entire practice that are going to walk around with a dismoster all below 0.5 because there are so many other options if we need them that we don't need to overly suppress cholesterol synthesis